Showing posts with label venous thromboembolism. Show all posts
Showing posts with label venous thromboembolism. Show all posts

Monday, December 07, 2009

Risk of blood clots after surgery is higher and lasts longer than thought

Studies have shown that the risk of developing blood clot after major surgery is high but a new study pubished in BMJ Online First on 4 December found that this risk is higher and continues for up to 3 months after surgery.

The research was a large prospective study that tracked 947,454 women, average age 56, who were diagnosed with venous thromboembolism through the NHS breast screening programme between 1996 and 2001. The reserachers checked hospital admission and death records, followed for an average of 6.2 years and compared the risk of blood clots for those who did not have surgery with those who did have surgery.

The researchers found that within 6 weeks post operation, women who had day case surgery were 10 times more likely to have blood clots than those who had no surgery. The risk for those who had surgery in the hospital were nearly 70 times higher. At 7 to 12 weeks after surgery, the risk of blood clots was 6 times higher for the day case surgery group than the no surgery group and 20 times higher for the inpatient surgery group.

They also calculated different risks for different surgery and found that the incidence of blood clots in the 12 weeks after surgey :
  • 1 in 45 had developed blood clots after hip or knee replacement;
  • 1 in 85 after cancer surgery;
  • 1 in 815 after day surgery;
  • 1 in 6,200 women who did not have surgery
The researchers warn that the risk of developing blood clot after surgery is higher and lasts for longer than previously thought and suggest that doctors should extend the time that preventive measures such as blood thinning drugs or wearing stockings are used.

Critics say that despite the lack of data on how many of the participants were taking preventive measures, this study is important because it broadens our understanding to current evidence of the risk of potential fatal blood clot after surgery and the findings may have implications for prolonged prophylaxis after surgery.

Source:
Editorial : Cohen TA. Prevention of postoperative venous thromboembolism. BMJ 2009; 339: b4477 (f/t via Athens)
Sweetland S, Green J, Liu B. et al. Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study. BMJ 2009; 339: b4583 ( f/t via Athens)

Wednesday, May 28, 2008

HRT pills double risk of blood clots

Researchers in France and Glasgow carried out a systematic review and meta-analysis on some studies looking at the risk of venous thromboembolism in women taking hormone replacement therapy HRT) - the BBC reported.


They concluded that "current use of oral oestrogen increases the risk of venous thromboembolism by twofold to threefold" and they said that HRT patch may be safer but further research is needed.


The critics say this new study provides valuable evidence about the size of the risks and gives some idea of the difference between patches and pills, but women should not assume that it is unsafe to take HRT pills or patches are safe.


Source: "Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis" BMJ, published 20 May 2008. Ahead of print ( f/t via Athens)

Wednesday, April 23, 2008

New blood clot drug could save thousands of lives

A new blood-thinning drug Pradaxa is now available for patients at risk of blood clots after surgery. It is available as a daily tablet and does not require constant monitoring as other drugs currently used to prevent venous thromboembolism in patients who have hip and knee replacement surgery, reported The Telegraph.


The thrombosis charity, Lifeblood, wants all hospitals to improve their risk assessments for blood clots in patients when they are first admitted to reduce the unnecessary deaths from the condition. Wider use of this new drug to stop blood clots could save thousands of lives a year.


See also previous post "Blood clot prevenetion lacking in hospital" on 4 February 2008.

Monday, February 04, 2008

Blood clot prevention lacking in hospitals

A study published in The Lancet based on the data from more than 68,000 patients worldwide found that about 52% of those patients were at risk of venous thromboembolism (VTE) - the most common preventable cause of in-hospital death because they did not get preventive treatment despite internationally accepted guidelines for prevention of VTE in hospitals.

In an accompanying commentary in the journal, the author said preventive medications can reduce the risk of pulmonary embolism by 75 % in general surgical patients and by 57 % in medical patients.

Source: "Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study" The Lancet 2008; 371(9610):387-394 ( full text via Athens)